Muscarinic therapies in Alzheimer's disease; from palliative treatments to disease modification (Q47689049)

4 February 2018

title

Muscarinic therapies in Alzheimer's disease; from palliative treatments to disease modification (English)

1 reference

4 February 2018

0 references

S Lovestone

1

0 references

publication date

1 January 1997

1 reference

4 February 2018

International Journal of Psychiatry in Clinical Practice

published in

1 reference

4 February 2018

volume

1

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

15-20

1 reference

4 February 2018

Alzheimer's disease: a treatment in sight?

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Topographical distribution of neurochemical changes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer's disease: a correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Acetylcholinesterase fibers and the development of senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Ageing: the cholinergic hypothesis of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Staurosporine, a protein kinase inhibitor, attenuates basal forebrain-lesion-induced amnesia and cholinergic neuronal deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Normal and abnormal biology of the beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer's disease: a central role for amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

The role of APP processing and trafficking pathways in the formation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Genetic and molecular advances in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Brain signal transduction disturbances in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Receptor-coupled amyloid precursor protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Differential expression of PKC isoforms and PC12 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Nerve growth factor activates calcium-insensitive protein kinase C-epsilon in PC-12 rat pheochromocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer's disease: paired helical filaments and cytomembranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Spongiform alterations in brain biopsies of presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Fetal-type phosphorylation of the tau in paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Signal transduction via the MAP kinases: proceed at your own RSK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13651509709069201

10.3109/13651509709069201

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018